Epidemiology, staging (new system), and prognosis of cutaneous melanoma
- PMID: 19914457
- DOI: 10.1016/j.cps.2009.07.001
Epidemiology, staging (new system), and prognosis of cutaneous melanoma
Abstract
Melanoma remains one of the most deadly of skin cancers and its incidence has been rising steadily throughout the past several decades. The risk factors associated with melanoma include external factors, such as exposure to ultraviolet radiation, and host factors, such as family history, history of dysplastic nevi, and number of nevi. The 2002 American Joint Committee on Cancer tumor-nodes-metastasis staging classification incorporates Breslow depth, Clark's level, ulceration, pathologic microstaging attributes, and nodal and distant metastases. Prognosis remains poor for advanced disease and surgery remains the mainstay of treatment for early stage melanoma.
Similar articles
-
Prognosis and staging in melanoma.Semin Oncol. 1996 Dec;23(6):725-33. Semin Oncol. 1996. PMID: 8970594 Review.
-
[Epidemiology and prognostic factors in cutaneous malignant melanoma].Harefuah. 1995 Jun 15;128(12):745-51, 824. Harefuah. 1995. PMID: 7557679 Hebrew.
-
Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.Ann Surg. 2009 Apr;249(4):641-7. doi: 10.1097/SLA.0b013e31819ed973. Ann Surg. 2009. PMID: 19300224
-
Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.Semin Oncol. 2007 Dec;34(6):491-7. doi: 10.1053/j.seminoncol.2007.09.005. Semin Oncol. 2007. PMID: 18083372 Review.
-
[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. doi: 10.1111/j.1610-0387.2005.05051.x. J Dtsch Dermatol Ges. 2005. PMID: 16033477 Review. German.
Cited by
-
A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.Aging (Albany NY). 2020 Apr 20;12(8):6966-6980. doi: 10.18632/aging.103054. Epub 2020 Apr 20. Aging (Albany NY). 2020. PMID: 32310824 Free PMC article.
-
The epidemiology of melanoma in young adults.Expert Rev Dermatol. 2013;8(6):707-716. doi: 10.1586/17469872.2013.844465. Expert Rev Dermatol. 2013. PMID: 40129654 Free PMC article.
-
Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.Cell Cycle. 2019 Nov;18(21):2860-2875. doi: 10.1080/15384101.2019.1638191. Epub 2019 Sep 4. Cell Cycle. 2019. Retraction in: Cell Cycle. 2022 Jul;21(13):1435. doi: 10.1080/15384101.2022.2066278. PMID: 31599708 Free PMC article. Retracted.
-
The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.Int J Oncol. 2018 Sep;53(3):949-960. doi: 10.3892/ijo.2018.4473. Epub 2018 Jul 6. Int J Oncol. 2018. PMID: 30015838 Free PMC article.
-
Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.Oncotarget. 2017 Jan 17;8(3):4147-4155. doi: 10.18632/oncotarget.13792. Oncotarget. 2017. PMID: 27926505 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
